Novelion Therapeutics Inc Asset Turnover Ratio (NVLN), as of first quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Novelion Therapeutics Inc   (NVLN)
 

Novelion Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Novelion Therapeutics Inc asset turnover ratio, the ability of Novelion Therapeutics Inc 's assets to generate revenue in the first quarter 2019, increased sequentially to 0.4 in the first quarter (Mar 31 2019), yet the ratio remained below the average, as NVLN's position remain challenging.

Within sector 120 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2019 compared to the preceding quarter from 2478 to 2661.

Asset Turnover Ratio Definition



NVLN Asset Turnover Ratio (Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
Y / Y Asset Change -4.56 % -7.48 % -20.41 % -22.7 % -19.83 %
Y / Y Revenue Change 17.16 % 4.63 % 5.81 % -21.95 % -8.34 %
Asset Turnover Ratio (TTM) 0.4 0.38 0.37 0.34 0.34
NVLN's Total Ranking # 2661 # 2478 # 2165 # 2652 # 2381
Seq. Asset Change 0.12 % 5.15 % -4.51 % -5.06 % -2.94 %
Seq. Revenue Change -20.9 % 34.21 % -4.92 % 16.08 % -29.36 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 121
Healthcare Sector # 331
Overall Market # 2661

Asset Turnover Ratio Statistics
High Average Low
8.99 7.12 5.65
(Dec 31 2017)   (Mar 31 2019)







Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2019 Assets at quarter ending Mar 31 2019
Vtv Therapeutics Inc   1.09 $ 11.291  Millions$ 10.403  Millions
Iridex Corp  1.09 $ 43.686  Millions$ 40.255  Millions
Accuray Incorporated  1.08 $ 415.154  Millions$ 383.180  Millions
Neurometrix Inc   1.08 $ 14.270  Millions$ 13.186  Millions
Rafina Innovations Inc.  1.08 $ 0.335  Millions$ 0.310  Millions
Puma Biotechnology Inc   1.08 $ 283.542  Millions$ 262.205  Millions
Stablecoin Development Corporation  1.07 $ 11.052  Millions$ 10.288  Millions
Infusystem Holdings Inc  1.06 $ 68.848  Millions$ 64.707  Millions
Harrow Inc   1.05 $ 44.797  Millions$ 42.645  Millions
Natera Inc   1.05 $ 262.138  Millions$ 250.322  Millions
Lhc Group Inc   1.05 $ 2,021.494  Millions$ 1,933.752  Millions
Cardiff Lexington Corporation  1.04 $ 3.030  Millions$ 2.915  Millions
Align Technology inc   1.02 $ 2,078.539  Millions$ 2,032.971  Millions
Inogen Inc   1.02 $ 369.262  Millions$ 363.460  Millions
Invacare Holdings Corporation  1.01 $ 958.706  Millions$ 945.942  Millions
Biomerica Inc   1.01 $ 5.165  Millions$ 5.097  Millions
Ufp Technologies Inc   1.01 $ 194.852  Millions$ 192.341  Millions
Lakeland Industries Inc   1.01 $ 99.351  Millions$ 98.225  Millions
Arena Pharmaceuticals Inc   1.00 $ 817.272  Millions$ 816.138  Millions
Lifeloc Technologies Inc   1.00 $ 8.305  Millions$ 8.294  Millions
United Cannabis Corp  0.99 $ 11.391  Millions$ 11.476  Millions
U S Physical Therapy Inc  0.99 $ 461.800  Millions$ 465.441  Millions
Orthofix Medical Inc   0.99 $ 453.445  Millions$ 459.472  Millions
Pressure Biosciences Inc   0.99 $ 2.357  Millions$ 2.389  Millions
Icagen, Inc.  0.98 $ 13.963  Millions$ 14.199  Millions
Glaukos Corp  0.98 $ 195.171  Millions$ 199.149  Millions
Seaspine Holdings Corporation  0.97 $ 146.418  Millions$ 150.965  Millions
Universal Health Services Inc   0.96 $ 10,889.153  Millions$ 11,332.440  Millions
Xtant Medical Holdings Inc   0.96 $ 70.995  Millions$ 73.886  Millions
Bruker Corporation  0.95 $ 1,925.300  Millions$ 2,016.550  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.